Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIDE: Hydralazine/Isosorbide Dinitrate in Hemodialysis
NCT02228408Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Aug 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydralazine, isosorbide dinitrate in end stage renal disease (ESRD), sponsored by Brigham and Women's Hospital. Started Aug 2017; status: completed.
02
Drugs
hydralazineisosorbide dinitrate
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT02228408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02228408.